Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 8 of 8 for “"Cancer theranostics"”.

  1. Leveraging Bio-Inspired Molecules for Cancer Theranostics

    … molecules can be radiolabeled and delivered to a cancer site for the purposes of diagnostics and therapy. Among the most promising of tumor targeting molecules are peptides and antibodies. These bio-inspired molecules can be designed and synthesized to target and respond to cancer cells based on …

    cuny-grad Repository record for Leveraging Bio-Inspired Molecules for Cancer Theranostics (opens in a new tab)

  2. Development of Gold-Magnetite Hybrid Nanoparticles for Advanced Radiotherapy

    The term “theranostics” defines the effort to develop individualized therapies by the combination of diagnostic and therapeutic functions in the same agent. Gold-magnetite hybrid nanoparticles (H-NPs) are proposed as innovative theranostic nanotools for imaging-guided radiosensitization of cancers. …

    trento Repository record for Development of Gold-Magnetite Hybrid Nanoparticles for Advanced Radiotherapy (opens in a new tab)

  3. Multifunctional Hybrid Theranostic Nanoplatforms for Cancer Imaging and Therapy

    Cancer remains a leading cause of morbidity and mortality worldwide, with millions of new cases diagnosed each year and a significant number of deaths attributed to the disease. Traditional cancer treatments like surgery, chemotherapy, and radiation therapy often face limitations, including …

    wustl Repository record for Multifunctional Hybrid Theranostic Nanoplatforms for Cancer Imaging and Therapy (opens in a new tab)

  4. Design, Synthesis and Development of Transporter Targeting Agents For Image-Guided Therapy and Drug Delivery

    … for tumor cell proliferation assessment and cancer theranostic platform, respectively. N4amG and GP were synthesized and radiolabeled with <sup>99m</sup>Tc and <sup>68</sup>Ga. The chemical and radiochemical purities as well as radiochemical stabilities of radiolabeled N4amG and GP were …

    uthsc Repository record for Design, Synthesis and Development of Transporter Targeting Agents For Image-Guided Therapy and Drug Delivery (opens in a new tab)

  5. Tailoring Intermolecular Interactions for High-Performance Nanocomposites

    … represent promising materials for photothermal cancer theranostics due to their size and stability. The efficient reaction of 2-isocyanatoethyl methacrylate with amines afforded urea-containing methacrylic monomers, where the amine-derived pendant groups determined the polymer Tg. Reversible …

    vt Repository record for Tailoring Intermolecular Interactions for High-Performance Nanocomposites (opens in a new tab)

  6. Shape-Engineering Substrate-Based Plasmonic Nanomaterials

    … door to promising applications in fields such as cancer theranostics, drug delivery, catalysis and sensing; the synthetic protocols for the placement of nanomaterials on surfaces, a requisite for chip-based devices, are ill-developed. This dissertation serves to address this limitation by …

    temple Repository record for Shape-Engineering Substrate-Based Plasmonic Nanomaterials (opens in a new tab)

  7. Design strategies and application of stimuli-responsive nanoparticles for cancer diagnosis and therapy

    Small molecule anticancer drugs are the first-line therapy used in clinical cancer management which has shown success in the killing of rapidly dividing cancer cells. However, nonspecific distribution of these small molecular therapeutics has adverse side effects reducing the quality of life. …

    ksu Repository record for Design strategies and application of stimuli-responsive nanoparticles for cancer diagnosis and therapy (opens in a new tab)

  8. Development and Evaluation of Novel Anti-HER2 Theranostics Against HER2-Positive Breast Cancer

    Breast cancer (BC) is the deadliest cancer type in women worldwide with high incidence (11.6%) and mortality (6.9%) rates. Human epidermal growth factor receptor 2 (HER2) is overexpressed in 20-30% of BC. HER2 overexpression is also observed in other cancers such as gastric/gastroesophageal, …

    sask Repository record for Development and Evaluation of Novel Anti-HER2 Theranostics Against HER2-Positive Breast Cancer (opens in a new tab)